Xeris Pharmaceuticals | XERS - Pre Tax Profit


Xeris Pharmaceuticals reported $11.08M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Celltrion KRW 14.6B 180.89B Jun/2025
Cspc Pharmaceutical CNY 1.21B 110.04M Sep/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 8.54B 580M Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Pacira USD 9.52M 11.45M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pharma Mar EUR 40.2M 44.28M Dec/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Sartorius EUR 85M 14.1M Sep/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
Tilray USD -39.96M 39.19M Sep/2025
Zealand Pharma A/S -406.5M 39.77M Dec/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025